Table 1.
Populations at increased risk for C. difficile
Patients who take the following drugs |
Antibiotics |
Proton pump inhibitors |
Valacyclovir |
Patient characteristics |
IBD |
Serous underlying illness-comorbidities |
Gastrointestinal surgery/manipulations |
Advanced age |
Immune-compromising conditions (post transplantation) |
Peri-partum |
Environment |
Prolonged stay in health-care settings |
Laboratory factors |
Hypoalbuminemia |
Low levels of anti-toxin and B antibodies |